お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は、抗真菌剤の世界市場、容量、生産量、収益、価格の概要を紹介します。2020~2024年の歴史的な市場収益/売上データ、2025年の予想、および2031年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別に抗真菌剤市場を分類しています。
本レポートでは世界の抗真菌剤市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：Abbott Laboratories、Astellas Pharma、Bayer、GlaxoSmithKline、Glenmark、Kramer Laboratories、Merck、Novartis、Pfizer、SCYNEXIS、Sanofi、Gilead Science、Enzon Pharmaceuticals

レポートは抗真菌剤の主要生産者を調査し、主要地域や国の消費状況も提供します。抗真菌剤の今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2020年から2031年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。
タイプ別市場セグメント：
    Powder
    Ointment
    Tablet
    Other

用途別の市場セグメント：
    Hospital
    Retail Pharmacy
    Online Pharmacy

本レポートの詳細内容
本レポートは、世界の抗真菌剤市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいて抗真菌剤市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2020年から2025年まで、そして2031年までの予測として、メーカー別、地域別（地域レベル、国レベル）の抗真菌剤生産量、成長率、市場シェアを調査している。

二. 消費面では、抗真菌剤の売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2020年から2025年まで、2031年までの予測。

三.主要メーカーの抗真菌剤売上高、収益、市場シェア、業界ランキング、2020年から2025年までのデータに焦点を当てています。世界の抗真菌剤市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本抗真菌剤のレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要
第1章：抗真菌剤のレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2020～2031）
第2章： 抗真菌剤の世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2020～2031）
第3章：世界、地域、国レベルにおける抗真菌剤の売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2020～2031）
第4章抗真菌剤メーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2020～2025）
第5章：抗真菌剤の各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2020～2031）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2020～2031）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2020～2031）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2020～2031）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2020～2031）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2020～2031）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2020～2031）
第12章：抗真菌剤の主要メーカーの概要を提供し、製品の説明と仕様、抗真菌剤の売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2020～2025）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：抗真菌剤の市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

Antifungal drugs are used to treat fungal infections, which most commonly affect your skin, hair and nails.

Market Analysis and Insights: Global Anti-fungal Drugs Market
The global Anti-fungal Drugs market is projected to grow from US$ 1819.6 million in 2024 to US$ 2097.9 million by 2030, at a Compound Annual Growth Rate (CAGR) of 2.4% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Anti-fungal Drugs market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Anti-fungal Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Anti-fungal Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Anti-fungal Drugs revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Anti-fungal Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Anti-fungal Drugs revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
    Abbott Laboratories
    Astellas Pharma
    Bayer
    GlaxoSmithKline
    Glenmark
    Kramer Laboratories
    Merck
    Novartis
    Pfizer
    SCYNEXIS
    Sanofi
    Gilead Science
    Enzon Pharmaceuticals

Segment by Type
    Powder
    Ointment
    Tablet
    Other

Segment by Application
    Hospital
    Retail Pharmacy
    Online Pharmacy

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Anti-fungal Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anti-fungal Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anti-fungal Drugs revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Anti-fungal Drugs Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Powder
    Table 3. Key Players of Ointment
    Table 4. Key Players of Tablet
    Table 5. Key Players of Other
    Table 6. Global Anti-fungal Drugs Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 7. Global Anti-fungal Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Anti-fungal Drugs Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global Anti-fungal Drugs Market Share by Region (2019-2024)
    Table 10. Global Anti-fungal Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global Anti-fungal Drugs Market Share by Region (2025-2030)
    Table 12. Anti-fungal Drugs Market Trends
    Table 13. Anti-fungal Drugs Market Drivers
    Table 14. Anti-fungal Drugs Market Challenges
    Table 15. Anti-fungal Drugs Market Restraints
    Table 16. Global Anti-fungal Drugs Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global Anti-fungal Drugs Revenue Share by Players (2019-2024)
    Table 18. Global Top Anti-fungal Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-fungal Drugs as of 2023)
    Table 19. Global Anti-fungal Drugs Industry Ranking 2022 VS 2023 VS 2024
    Table 20. Global 5 Largest Players Market Share by Anti-fungal Drugs Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Global Key Players of Anti-fungal Drugs, Headquarters and Area Served
    Table 22. Global Key Players of Anti-fungal Drugs, Product and Application
    Table 23. Global Key Players of Anti-fungal Drugs, Product and Application
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Anti-fungal Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global Anti-fungal Drugs Revenue Market Share by Type (2019-2024)
    Table 27. Global Anti-fungal Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global Anti-fungal Drugs Revenue Market Share by Type (2025-2030)
    Table 29. Global Anti-fungal Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 30. Global Anti-fungal Drugs Revenue Share by Application (2019-2024)
    Table 31. Global Anti-fungal Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 32. Global Anti-fungal Drugs Revenue Share by Application (2025-2030)
    Table 33. North America Anti-fungal Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 34. North America Anti-fungal Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 35. North America Anti-fungal Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 36. North America Anti-fungal Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 37. North America Anti-fungal Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 38. North America Anti-fungal Drugs Market Size by Country (2019-2024) & (US$ Million)
    Table 39. North America Anti-fungal Drugs Market Size by Country (2025-2030) & (US$ Million)
    Table 40. Europe Anti-fungal Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 41. Europe Anti-fungal Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 42. Europe Anti-fungal Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 43. Europe Anti-fungal Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 44. Europe Anti-fungal Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Europe Anti-fungal Drugs Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Europe Anti-fungal Drugs Market Size by Country (2025-2030) & (US$ Million)
    Table 47. China Anti-fungal Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 48. China Anti-fungal Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 49. China Anti-fungal Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 50. China Anti-fungal Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 51. Asia Anti-fungal Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 52. Asia Anti-fungal Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 53. Asia Anti-fungal Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 54. Asia Anti-fungal Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 55. Asia Anti-fungal Drugs Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 56. Asia Anti-fungal Drugs Market Size by Region (2019-2024) & (US$ Million)
    Table 57. Asia Anti-fungal Drugs Market Size by Region (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Anti-fungal Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Anti-fungal Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Anti-fungal Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Anti-fungal Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Anti-fungal Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 63. Middle East, Africa, and Latin America Anti-fungal Drugs Market Size by Country (2019-2024) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Anti-fungal Drugs Market Size by Country (2025-2030) & (US$ Million)
    Table 65. Abbott Laboratories Company Details
    Table 66. Abbott Laboratories Business Overview
    Table 67. Abbott Laboratories Anti-fungal Drugs Product
    Table 68. Abbott Laboratories Revenue in Anti-fungal Drugs Business (2019-2024) & (US$ Million)
    Table 69. Abbott Laboratories Recent Developments
    Table 70. Astellas Pharma Company Details
    Table 71. Astellas Pharma Business Overview
    Table 72. Astellas Pharma Anti-fungal Drugs Product
    Table 73. Astellas Pharma Revenue in Anti-fungal Drugs Business (2019-2024) & (US$ Million)
    Table 74. Astellas Pharma Recent Developments
    Table 75. Bayer Company Details
    Table 76. Bayer Business Overview
    Table 77. Bayer Anti-fungal Drugs Product
    Table 78. Bayer Revenue in Anti-fungal Drugs Business (2019-2024) & (US$ Million)
    Table 79. Bayer Recent Developments
    Table 80. GlaxoSmithKline Company Details
    Table 81. GlaxoSmithKline Business Overview
    Table 82. GlaxoSmithKline Anti-fungal Drugs Product
    Table 83. GlaxoSmithKline Revenue in Anti-fungal Drugs Business (2019-2024) & (US$ Million)
    Table 84. GlaxoSmithKline Recent Developments
    Table 85. Glenmark Company Details
    Table 86. Glenmark Business Overview
    Table 87. Glenmark Anti-fungal Drugs Product
    Table 88. Glenmark Revenue in Anti-fungal Drugs Business (2019-2024) & (US$ Million)
    Table 89. Glenmark Recent Developments
    Table 90. Kramer Laboratories Company Details
    Table 91. Kramer Laboratories Business Overview
    Table 92. Kramer Laboratories Anti-fungal Drugs Product
    Table 93. Kramer Laboratories Revenue in Anti-fungal Drugs Business (2019-2024) & (US$ Million)
    Table 94. Kramer Laboratories Recent Developments
    Table 95. Merck Company Details
    Table 96. Merck Business Overview
    Table 97. Merck Anti-fungal Drugs Product
    Table 98. Merck Revenue in Anti-fungal Drugs Business (2019-2024) & (US$ Million)
    Table 99. Merck Recent Developments
    Table 100. Novartis Company Details
    Table 101. Novartis Business Overview
    Table 102. Novartis Anti-fungal Drugs Product
    Table 103. Novartis Revenue in Anti-fungal Drugs Business (2019-2024) & (US$ Million)
    Table 104. Novartis Recent Developments
    Table 105. Pfizer Company Details
    Table 106. Pfizer Business Overview
    Table 107. Pfizer Anti-fungal Drugs Product
    Table 108. Pfizer Revenue in Anti-fungal Drugs Business (2019-2024) & (US$ Million)
    Table 109. Pfizer Recent Developments
    Table 110. SCYNEXIS Company Details
    Table 111. SCYNEXIS Business Overview
    Table 112. SCYNEXIS Anti-fungal Drugs Product
    Table 113. SCYNEXIS Revenue in Anti-fungal Drugs Business (2019-2024) & (US$ Million)
    Table 114. SCYNEXIS Recent Developments
    Table 115. Sanofi Company Details
    Table 116. Sanofi Business Overview
    Table 117. Sanofi Anti-fungal Drugs Product
    Table 118. Sanofi Revenue in Anti-fungal Drugs Business (2019-2024) & (US$ Million)
    Table 119. Sanofi Recent Developments
    Table 120. Gilead Science Company Details
    Table 121. Gilead Science Business Overview
    Table 122. Gilead Science Anti-fungal Drugs Product
    Table 123. Gilead Science Revenue in Anti-fungal Drugs Business (2019-2024) & (US$ Million)
    Table 124. Gilead Science Recent Developments
    Table 125. Enzon Pharmaceuticals Company Details
    Table 126. Enzon Pharmaceuticals Business Overview
    Table 127. Enzon Pharmaceuticals Anti-fungal Drugs Product
    Table 128. Enzon Pharmaceuticals Revenue in Anti-fungal Drugs Business (2019-2024) & (US$ Million)
    Table 129. Enzon Pharmaceuticals Recent Developments
    Table 130. Research Programs/Design for This Report
    Table 131. Key Data Information from Secondary Sources
    Table 132. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Anti-fungal Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Anti-fungal Drugs Market Share by Type: 2023 VS 2030
    Figure 3. Powder Features
    Figure 4. Ointment Features
    Figure 5. Tablet Features
    Figure 6. Other Features
    Figure 7. Global Anti-fungal Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global Anti-fungal Drugs Market Share by Application: 2023 VS 2030
    Figure 9. Hospital Case Studies
    Figure 10. Retail Pharmacy Case Studies
    Figure 11. Online Pharmacy Case Studies
    Figure 12. Anti-fungal Drugs Report Years Considered
    Figure 13. Global Anti-fungal Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global Anti-fungal Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Anti-fungal Drugs Market Share by Region: 2023 VS 2030
    Figure 16. Global Anti-fungal Drugs Market Share by Players in 2023
    Figure 17. Global Top Anti-fungal Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-fungal Drugs as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by Anti-fungal Drugs Revenue in 2023
    Figure 19. North America Anti-fungal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America Anti-fungal Drugs Market Share by Type (2019-2030)
    Figure 21. North America Anti-fungal Drugs Market Share by Application (2019-2030)
    Figure 22. North America Anti-fungal Drugs Market Share by Country (2019-2030)
    Figure 23. United States Anti-fungal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Canada Anti-fungal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Anti-fungal Drugs Market Size YoY (2019-2030) & (US$ Million)
    Figure 26. Europe Anti-fungal Drugs Market Share by Type (2019-2030)
    Figure 27. Europe Anti-fungal Drugs Market Share by Application (2019-2030)
    Figure 28. Europe Anti-fungal Drugs Market Share by Country (2019-2030)
    Figure 29. Germany Anti-fungal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. France Anti-fungal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. U.K. Anti-fungal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Italy Anti-fungal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Russia Anti-fungal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Nordic Countries Anti-fungal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. China Anti-fungal Drugs Market Size YoY (2019-2030) & (US$ Million)
    Figure 36. China Anti-fungal Drugs Market Share by Type (2019-2030)
    Figure 37. China Anti-fungal Drugs Market Share by Application (2019-2030)
    Figure 38. Asia Anti-fungal Drugs Market Size YoY (2019-2030) & (US$ Million)
    Figure 39. Asia Anti-fungal Drugs Market Share by Type (2019-2030)
    Figure 40. Asia Anti-fungal Drugs Market Share by Application (2019-2030)
    Figure 41. Asia Anti-fungal Drugs Market Share by Region (2019-2030)
    Figure 42. Japan Anti-fungal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. South Korea Anti-fungal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. China Taiwan Anti-fungal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Anti-fungal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. India Anti-fungal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Australia Anti-fungal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Anti-fungal Drugs Market Size YoY (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Anti-fungal Drugs Market Share by Type (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Anti-fungal Drugs Market Share by Application (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Anti-fungal Drugs Market Share by Country (2019-2030)
    Figure 52. Brazil Anti-fungal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Mexico Anti-fungal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Turkey Anti-fungal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Saudi Arabia Anti-fungal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Israel Anti-fungal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. GCC Countries Anti-fungal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Abbott Laboratories Revenue Growth Rate in Anti-fungal Drugs Business (2019-2024)
    Figure 59. Astellas Pharma Revenue Growth Rate in Anti-fungal Drugs Business (2019-2024)
    Figure 60. Bayer Revenue Growth Rate in Anti-fungal Drugs Business (2019-2024)
    Figure 61. GlaxoSmithKline Revenue Growth Rate in Anti-fungal Drugs Business (2019-2024)
    Figure 62. Glenmark Revenue Growth Rate in Anti-fungal Drugs Business (2019-2024)
    Figure 63. Kramer Laboratories Revenue Growth Rate in Anti-fungal Drugs Business (2019-2024)
    Figure 64. Merck Revenue Growth Rate in Anti-fungal Drugs Business (2019-2024)
    Figure 65. Novartis Revenue Growth Rate in Anti-fungal Drugs Business (2019-2024)
    Figure 66. Pfizer Revenue Growth Rate in Anti-fungal Drugs Business (2019-2024)
    Figure 67. SCYNEXIS Revenue Growth Rate in Anti-fungal Drugs Business (2019-2024)
    Figure 68. Sanofi Revenue Growth Rate in Anti-fungal Drugs Business (2019-2024)
    Figure 69. Gilead Science Revenue Growth Rate in Anti-fungal Drugs Business (2019-2024)
    Figure 70. Enzon Pharmaceuticals Revenue Growth Rate in Anti-fungal Drugs Business (2019-2024)
    Figure 71. Bottom-up and Top-down Approaches for This Report
    Figure 72. Data Triangulation
    Figure 73. Key Executives Interviewed